Niels D. Guchelaar

Rotterdam, ZH, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 27 publications

The Effect of Taking Cabozantinib with a Light Breakfast: A Randomized Crossover Pharmacokinetic Study (SKIPPY 1).

The Effect of Taking Cabozantinib with a Light Breakfast: A Randomized Crossover Pharmacokinetic Study (SKIPPY 1).

Journal: Clinical pharmacokinetics

Published: August 20, 2025

Phase I study of intraperitoneal irinotecan with systemic capecitabine and oxaliplatin for patients with gastric peritoneal metastases.

Phase I study of intraperitoneal irinotecan with systemic capecitabine and oxaliplatin for patients with gastric peritoneal metastases.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: July 23, 2025

A Clinical Pharmacological Perspective on Intraperitoneal Chemotherapy.

A Clinical Pharmacological Perspective on Intraperitoneal Chemotherapy.

Journal: Drugs

Published: April 23, 2025

Staging laparoscopy for gastric cancer: European consensus.

Staging laparoscopy for gastric cancer: European consensus.

Journal: The British journal of surgery

Published: December 30, 2024

Pharmacokinetic boosting of olaparib: Study protocol of a multicentre, open-label, randomised, non-inferiority trial (PROACTIVE-B).

Pharmacokinetic boosting of olaparib: Study protocol of a multicentre, open-label, randomised, non-inferiority trial (PROACTIVE-B).

Journal: Contemporary clinical trials communications

Published: November 05, 2024

The prognostic value of peritoneal metastases in patients with gastric cancer: a nationwide population-based study.

The prognostic value of peritoneal metastases in patients with gastric cancer: a nationwide population-based study.

Journal: EClinicalMedicine

Published: October 10, 2024

Trifluridine-tipiracil in previously treated patients with oestrogen receptor-positive, HER2-negative metastatic breast cancer (BOOG 2019-01 TIBET trial): a single-arm, multicentre, phase 2 trial.

Trifluridine-tipiracil in previously treated patients with oestrogen receptor-positive, HER2-negative metastatic breast cancer (BOOG 2019-01 TIBET trial): a single-arm, multicentre, phase 2 trial.

Journal: EClinicalMedicine

Published: September 05, 2024

Evaluating the Clinical Impact and Feasibility of Therapeutic Drug Monitoring of Pazopanib in a Real-World Soft-Tissue Sarcoma Cohort.

Evaluating the Clinical Impact and Feasibility of Therapeutic Drug Monitoring of Pazopanib in a Real-World Soft-Tissue Sarcoma Cohort.

Journal: Clinical pharmacokinetics

Published: June 24, 2024

The OCT2/MATE1 Interaction Between Trifluridine, Metformin and Cimetidine: A Crossover Pharmacokinetic Study.

The OCT2/MATE1 Interaction Between Trifluridine, Metformin and Cimetidine: A Crossover Pharmacokinetic Study.

Journal: Clinical pharmacokinetics

Published: May 30, 2024

Therapeutic Drug Monitoring of Oral Oncology Drugs: Finding the Right Nails.

Therapeutic Drug Monitoring of Oral Oncology Drugs: Finding the Right Nails.

Journal: Clinical pharmacology and therapeutics

Published: April 19, 2024

Reasons for non-feasibility of therapeutic drug monitoring of oral targeted therapies in oncology - an analysis of the closed cohorts of a multicentre prospective study.

Reasons for non-feasibility of therapeutic drug monitoring of oral targeted therapies in oncology - an analysis of the closed cohorts of a multicentre prospective study.

Journal: British journal of cancer

Published: April 15, 2024

Intraperitoneal pharmacokinetics of systemic oxaliplatin, 5-fluorouracil and bevacizumab in patients with colorectal peritoneal metastases.

Intraperitoneal pharmacokinetics of systemic oxaliplatin, 5-fluorouracil and bevacizumab in patients with colorectal peritoneal metastases.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: March 29, 2024

Showing 1-12 of 27

Last Updated: 09/26/2026